Grants per year
Personal profile
Training Experience
| 2010 | Postdoctoral Fellowship, Northwestern University Feinberg School of Medicine |
Education/Academic qualification
PhD, University of Rostock
… → 1995
MD, University of Rostock
… → 1994
Fingerprint Dive into the research topics where Jan Wysocki is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Angiotensin II
Medicine & Life Sciences
Kidney
Medicine & Life Sciences
Diabetic Nephropathies
Medicine & Life Sciences
Renin-Angiotensin System
Medicine & Life Sciences
Peptidyl-Dipeptidase A
Medicine & Life Sciences
Hypertension
Medicine & Life Sciences
Angiotensins
Medicine & Life Sciences
Blood Pressure
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2007 2020
Urinary Renin Angiotensin System in Diabetes
Batlle, D., Molitch, M. E., Rademaker, A. W. & Wysocki, J.
National Institute of Diabetes, Digestive and Kidney Diseases
6/15/15 → 4/30/20
Project: Research project
Renin-Angiotensin System
Renin
Diabetes Complications
Type 1 Diabetes Mellitus
Albuminuria
ACE2 as Therapeutic Target for Kidney Disease in Diabetic Mice
12/1/07 → 6/30/11
Project: Research project
Research Output 2004 2020
Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent
Serfozo, P., Wysocki, J., Gulua, G., Schulze, A., Ye, M., Liu, P., Jin, J., Bader, M., Myöhänen, T., García-Horsman, J. A. & Batlle, D., Jan 1 2020, In : Hypertension (Dallas, Tex. : 1979). 75, 1, p. 173-182 10 p.Research output: Contribution to journal › Article
Angiotensin II
lysosomal Pro-X carboxypeptidase
Kidney
Lung
angiotensin I (1-7)
1
Citation
(Scopus)
Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus
For the Diabetes Control, Complications Trial (DCCT)/Epidemiology of Diabetes Interventions, Complications (EDIC) Study, Oct 1 2019, In : Physiological reports. 7, 19, e14242.Research output: Contribution to journal › Article
Open Access
Angiotensinogen
Type 1 Diabetes Mellitus
Chronic Renal Insufficiency
Diabetes Complications
Kidney
2
Citations
(Scopus)
Urinary Renin in Patients and Mice With Diabetic Kidney Disease
Tang, J., Wysocki, J., Ye, M., Vallés, P. G., Rein, J., Shirazi, M., Bader, M., Gomez, R. A., Sequeira-Lopez, M-L. S., Afkarian, M. & Batlle, D., Jul 2019, In : Hypertension (Dallas, Tex. : 1979). 74, 1, p. 83-94 12 p.Research output: Contribution to journal › Article
Diabetic Nephropathies
Renin
Experimental Diabetes Mellitus
Diabetes Mellitus
Streptozocin
Apelinergic system in the kidney: implications for diabetic kidney disease
Müller, T., Kalea, A. Z., Marquez, A., Hsieh, I., Haque, S., Ye, M., Wysocki, J., Bader, M. & Batlle, D., Dec 2018, In : Physiological reports. 6, 23, e13939.Research output: Contribution to journal › Article
Podocytes
Diabetic Nephropathies
Kidney
Glucose
Angiotensin II
5
Citations
(Scopus)
Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation
Liu, P., Wysocki, J., Souma, T., Ye, M., Ramirez, V., Zhou, B., Wilsbacher, L. D., Quaggin, S. E., Batlle, D. & Jin, J., Jul 1 2018, In : Kidney international. 94, 1, p. 114-125 12 p.Research output: Contribution to journal › Article
Renin-Angiotensin System
Angiotensin II
Hypertension
Blood Pressure
Transgenic Mice